✦ LIBER ✦

Quantitative Measurement of Epidermal Growth Factor Receptor Is a Negative Predictive Factor for Tamoxifen Response in Hormone Receptor–Positive Premenopausal Breast Cancer

✍ Scribed by Ross, J.S.

Book ID: 122797217
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 76 KB
Volume: 19
Category: Article
ISSN: 1043-321X
DOI: 10.1016/S1043-321X(08)80121-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P59 Quantitative measurement of EGFR is

P59 Quantitative measurement of EGFR is a predictive factor for tamoxifen response in hormone receptor positive premenopausal breast cancer

✍ L. Rydén; J. Giltnane; M. Cregger; K. Jirström; P. Bendahl; D. Rimm 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Everolimus plus exemestane for hormone-r

Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2

✍ Piccart, M.; Hortobagyi, G. N.; Campone, M.; Pritchard, K. I.; Lebrun, F.; Ito, 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 142 KB

Epidermal growth factor receptor (EGFr)

Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: Neu and tamoxifen failure

✍ Nicholson, Stewart; Wright, Christopher; Richard C. Sainsbury, J.; Halcrow, Paul 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 275 KB

Prognostic value of positive human epide

Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer

✍ Lorenzo Livi; Icro Meattini; Calogero Saieva; Ciro Franzese; Vanessa Di Cataldo; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB

Economic evaluation of the 70-gene progn

Economic evaluation of the 70-gene prognosis-signature (MammaPrint®) in hormone receptor-positive, lymph node-negative, human epidermal growth factor receptor type 2-negative early stage breast cancer in Japan

✍ Masahide Kondo, Shu-Ling Hoshi, Hiroshi Ishiguro, Masakazu Toi 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 281 KB

Double-Blind, Placebo-Controlled, Multic

Double-Blind, Placebo-Controlled, Multicenter, Randomized, Phase IIB Neoadjuvant Study of Letrozole-Lapatinib in Postmenopausal Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, Operable Breast Cancer

✍ Guarneri, V.; Generali, D. G.; Frassoldati, A.; Artioli, F.; Boni, C.; Cavanna, 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 157 KB